Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1865-8652
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study ; volume:36 ; number:11 ; day:4 ; month:10 ; year:2019 ; pages:3017-3029 ; date:11.2019
Advances in therapy ; 36, Heft 11 (4.10.2019), 3017-3029, 11.2019

Creator
Gidman, Wendy
Shah, Shweta
Zhang, Lirong
McKendrick, Jan
Cong, Ze
Cohan, David
Ottmann, Oliver
Contributor
SpringerLink (Online service)

DOI
10.1007/s12325-019-01099-x
URN
urn:nbn:de:101:1-2020021622552204531375
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Gidman, Wendy
  • Shah, Shweta
  • Zhang, Lirong
  • McKendrick, Jan
  • Cong, Ze
  • Cohan, David
  • Ottmann, Oliver
  • SpringerLink (Online service)

Other Objects (12)

Minimal Residual Disease in Acute Lymphoblastic Leukemia

Minimal Residual Disease in Acute Lymphoblastic Leukemia

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia

Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions

Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions

Advanced minimal residual disease monitoring for acute lymphoblastic leukemia with multiplex mediator probe PCR

Advanced minimal residual disease monitoring for acute lymphoblastic leukemia with multiplex mediator probe PCR

Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?

Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?

Mean residual life cure models for right‐censored data with and without length‐biased sampling

Mean residual life cure models for right‐censored data with and without length‐biased sampling

Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey

Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey

Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia

Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia

ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?

ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?

Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case report

Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case report

Travel with Diabetes: A Comprehensive Review for Clinicians

Travel with Diabetes: A Comprehensive Review for Clinicians

Modelling reassurances of clinicians with hidden Markov models

Modelling reassurances of clinicians with hidden Markov models

Related objects